ESC Premium Access

Cardiovascular benefits outweigh risks in patients with atrial fibrillation in REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial)

Presentation

About the speaker

Professor Brian Olshansky

VETERANS HEALTH ADMINISTRATION, Iowa City (United States of America)
2 presentations
0 follower

36 more presentations in this session

Masters Athlete Screening Study (MASS): incidence of cardiovascular disease and major adverse cardiac events over five years of screening

Speaker: Ms B. Morrison (Vancouver, CA)

Thumbnail

Cardiopulmonary examinations of athletes returning to high-intensity sport activity following SARS-CoV-2 infection

Speaker: Assistant Professor O. Kiss (Budapest, HU)

Thumbnail

Exercise training induces benign right ventricular hypertrophy along with functional improvement and without pathological processes or arrhythmogenicity in a rodent model of athletes heart

Speaker: Doctor A. Olah (Budapest, HU)

Thumbnail

Characterisation of ventricular premature beats during exercise testing in masters athletes

Speaker: Doctor S. Fyyaz (London, GB)

Thumbnail

Determinants of high-risk coronary artery disease in ostensibly healthy male master endurance athletes.

Speaker: Doctor G. Parry-Williams (London, GB)

Thumbnail

Access the full session

Congress committee e-posters choice in preventive cardiology and special populations

Speakers: Professor B. Olshansky, Ms B. Morrison, Assistant Professor O. Kiss, Doctor A. Olah, Doctor S. Fyyaz...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

COVID-19 & digital health: is techcelleration here to stay? Let's discuss

22 October 2021

ESC Premium Access

COVID-19 & digital health: techcelleration here to stay?

22 October 2021

ESC Premium Access

The ESC journey and future directions.

22 October 2021

This platform is supported by

logo Novo Nordisk